tradingkey.logo

N2OFF Inc

NITO
查看詳細走勢圖
1.630USD
-0.180-9.94%
收盤 01/23, 16:00美東報價延遲15分鐘
2.24M總市值
虧損本益比TTM

N2OFF Inc

1.630
-0.180-9.94%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-9.94%

5天

+0.62%

1月

-28.51%

6月

-86.12%

今年開始到現在

-2.98%

1年

-96.18%

查看詳細走勢圖

TradingKey N2OFF Inc股票評分

單位: USD 更新時間: 2026-01-23

操作建議

N2OFF Inc當前公司基本面數據相對非常健康,增長潛力穩定。當前估值合理,在化學品行業排名64/69位。機構持股佔比非常高,中期看,股價處於下降通道。近一個月,市場表現非常差,但技術面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

N2OFF Inc評分

相關信息

行業排名
64 / 69
全市場排名
457 / 4538
所屬行業
化學品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

N2OFF Inc亮點

亮點風險
N2OFF, Inc. is a cleantech company mainly engaged in European Union (EU) based solar assets using the Ready to Build (RTB) business model. The Company is an investor in four solar projects in three different EU countries. It collaborates with Solterra Renewable Energy Ltd., an Israeli corporation and a wholly owned subsidiary of Solterra Energy Ltd., an Israeli corporation, which operates in the solar energy sector and presents certain investment opportunities in solar photovoltaic (PV) projects. The Company also controls approximately 98% of Save Foods Ltd., an Israeli company focused on post-harvest treatments in fruit and vegetables to control and prevent pathogen contamination. The Company’s solutions are focused on improving the food safety and shelf life of fresh produce. The Company, through its subsidiary, MitoCareX Bio Ltd., is focused on the development of novel therapies for hard-to-treat cancers by targeting proteins belonging to the mitochondrial SLC25 protein family.
業績增長期
公司處於發展階段,最新年度總收入210.00K美元
估值低估
公司最新PB估值0.25,處於3年歷史低位
機構減倉
最新機構持股40.20K股,環比減少30.66%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉0.00股

分析師目標

基於 0 分析師
--
評級
--
目標均價
--
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

N2OFF Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

N2OFF Inc簡介

N2OFF, Inc. is a cleantech company mainly engaged in European Union (EU) based solar assets using the Ready to Build (RTB) business model. The Company is an investor in four solar projects in three different EU countries. It collaborates with Solterra Renewable Energy Ltd., an Israeli corporation and a wholly owned subsidiary of Solterra Energy Ltd., an Israeli corporation, which operates in the solar energy sector and presents certain investment opportunities in solar photovoltaic (PV) projects. The Company also controls approximately 98% of Save Foods Ltd., an Israeli company focused on post-harvest treatments in fruit and vegetables to control and prevent pathogen contamination. The Company’s solutions are focused on improving the food safety and shelf life of fresh produce. The Company, through its subsidiary, MitoCareX Bio Ltd., is focused on the development of novel therapies for hard-to-treat cancers by targeting proteins belonging to the mitochondrial SLC25 protein family.
公司代碼NITO
公司N2OFF Inc
CEOSztybel (Dan)
網址https://www.n2off.com/
KeyAI